Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment
Saade Abdalkareem JasimMedical Laboratory Techniques Department, Al-Maarif University College, Anbar, IraqI.M. FarberDepartment of children's diseases of the F. Filatov clinical institute of children's health, I. M. Sechenov First Moscow State Medical University of Health of Russian Federation (Sechenov University), Moscow, RussiaSara Abdalrazzaq M. NoraldeenDepartment of Oncology and Metabolism, University of Tabuk, Tabuk, Saudi ArabiaPooja BansalDepartment of Biotechnology and Genetics, Jain (Deemed-to-be) University, Bengaluru, Karnataka 560069, India; Department of Allied Healthcare and Sciences, Vivekananda Global University, Jaipur, Rajasthan 303012, IndiaHashem O. AlsaabDepartment of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 21944, Saudi ArabiaBekhzod AbdullaevResearch Department of Biotechnology, New Uzbekistan University, Mustaqillik Avenue 54, Tashkent 100007, Uzbekistan; Department of Oncology, School of Medicine, Central Asian University, Milliy Bog Street 264, Tashkent 111221, Uzbekistan.. Electronic address: [email protected]Adnan Taan AlkhafajiCardiology Department, College of Medicine, Al-Ayen University, Thi-Qar, IraqAhmed AlawadiCollege of Technical Engineering, the Islamic University of Al Diwaniyah, Qadisiyyah, IraqHamza Fadhel HamzahDepartment of Medical Laboratories Technology, AL-Nisour University College, Baghdad, IraqBahira Abdulrazzaq MohammedDepartment of Technical Engineering, Al-Hadi University College, Baghdad 10011, Iraq
ABI
Abstract
No abstract available.
Topics
Identifiers
Citations and references
Cited by 0130 references
Metrics — AkademScholar · Coming soon